Systems biology in IPF: why we need to integrate

T. Maher (London, United Kingdom)

Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Number: 3
Disease area: Interstitial lung diseases

PDF journal article, handout or slidesSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Maher (London, United Kingdom). Systems biology in IPF: why we need to integrate. ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systems biology in respiratory medicine: bringing the pieces together
Source: International Congress 2017 – Towards personalised medicine for airways diseases: Deep phenotyping using omics approaches will revolutionise future treatment strategies
Year: 2017


Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges
Source: Eur Respir J, 55 (1) 1900844; 10.1183/13993003.00844-2019
Year: 2020



Integrating it all: systems biology
Source: ERS Research Seminar 2015
Year: 2015


Systems medicine advances in interstitial lung disease
Source: Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
Year: 2017



Systems medicine of COPD
Source: International Congress 2017 – Towards personalised medicine for airways diseases: Deep phenotyping using omics approaches will revolutionise future treatment strategies
Year: 2017


Systems biology, animal models and drug discovery
Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding
Year: 2008


HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012


Scene-setting: why do we need genomics and proteomics to understand pathology?
Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease
Year: 2004

Genomics and system biology: where does it take us in the future?
Source: Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease
Year: 2011



Systems pharmacology
Source: ERS Lung Science Conference 2016
Year: 2016




The pathogenesis of IPF: what is the latest paradigm?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019

Systems biology: 21st century science
Source: Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Year: 2012



How to build a lung: latest advances and emerging themes in lung bioengineering
Source: Eur Respir J, 52 (1) 1601355; 10.1183/13993003.01355-2016
Year: 2018



Genetics, genomics and a systems approach to asthma
Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding
Year: 2008


The biology of COPD
Source: International Congress 2019 – An update on chronic obstructive pulmonary disease
Year: 2019


New outlook on the Th1/Th2-alternative signaling pathways in asthma
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013